In June 2025, Cerapedics secured FDA premarket approval for its PearlMatrix™ P-15 Peptide Enhanced Bone Graft.

Few debates in knee arthroplasty spark as much polite-but-pointed hallway chatter as the fixation question: cemented or ...

Orthofix Medical, Inc. reported $203.121 million in sales and ($16,003) million in operating losses for the quarter ending ...

A worried parent, a stoic (or not-so-stoic) child, and a pediatric back pain story that may or may not rival an epic saga.

In sports medicine, the holy grail for anterior cruciate ligament reconstruction (ACLR) is simple: less pain, faster recovery ...

Integra LifeSciences Holdings Corporation reported $415.6 million in sales and ($512.674) million in operating losses for the ...

In an industry where everyone talks about “disrupting” spine, Demetra Holding S.p.A. might actually be doing it.

A new systematic review and meta-analysis in The Journal of Bone and Joint Surgery (July 29, 2025) is asking a question that ...

According to a new meta-analysis in the July 13, 2025, Journal of Experimental Orthopaedics, you’ll need to perform somewhere ...

CONMED’s 2Q25 numbers are in, and the picture is a mix of solid topline growth, orthopedic momentum, and some capital-market ...

Come October 1, Medicare is officially sweetening the deal for cervical fusion procedures using Carlsmed, Inc.’s aprevo® personalized interbody implants.

It's time to stop casually watching Alphatec Holdings, Inc. and start paying attention—they're not just growing, they’re ...